Blogs | MedChemExpress

Panobinostat is a Potent and Orally Active Non-selective HDAC Inhibitor

Panobinostat, a potent and orally active non-selective HDAC inhibitor, exhibits antineoplastic activities.
AUTAC4 is a Mitochondria-targeting Autophagy-targeting Chimera (AUTAC).

AUTAC4 is a Mitochondria-targeting Autophagy-targeting Chimera (AUTAC) and rescues cells with acute mitochondrial injury.
Henatinib is an Orally Active Multikinase Inhibitor with Broad Antitumor Activities

Henatinib is an orally active small-molecule multikinase inhibitor that has demonstrated broad and potent antitumor activities.
PSB-SB-487 is a Potent GPR55 Antagonist

PSB-SB-487, a Coumarin derivative, is a potent GPR55 antagonist, and is also a partial CB2 receptor agonist.
Tiragolumab is An Immune Checkpoint Inhibitor Binding to T-cell Immunoglobulin and TIGIT

Tiragolumab is an immune checkpoint inhibitor binding to TIGIT. Tiragolumab is effective against multiple solid malignancies.
Pulrodemstat is a Potent, Selective, Reversible and Orally Active Inhibitor of LSD1

Pulrodemstat is a potent, selective, reversible and orally active LSD1 inhibitor, with anticancer effects.
LDN-211904 is a Potent and Selective EphB3 Inhibitor for Colorectal Cancer Research

LDN-211904 oxalate is a potent and selective EphB3 inhibitor and combines with cetuximab can overcome cetuximab resistance.
RKI-1313 is a Potent ROCK1/2 inhibitor

RKI-1313 is a potent ROCK inhibitor and shows little effect on the phosphorylation levels of ROCK substrates, migration, invasion.
Toceranib is An Orally Active Inhibitor of Receptor Tyrosine Kinase (RTK)

Toceranib is a selective and orally active inhibitor of RTK and has the potential for the research of canine mast cell tumors.
AZD7254 is An Orally Active Smoothened (SMO) Inhibitor With Anti-Cancer Effects

AZD7254 is a potent and orally active Smoothened (SMO) inhibitor, against sonic Hh protein (shh), with strong anti-cancer effects.

Name
Email *

	Sorry, but the email address you supplied was invalid.

Blogs (12)